Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−28.02USD
−62.01 MUSD
412.00 KUSD
1.67 M
About TALIS BIOMEDICAL CORP
Sector
Industry
CEO
Robert J. Kelley
Website
Headquarters
Chicago
Employees (FY)
99
Founded
2013
FIGI
BBG00Z0Z98V3
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.
Frequently Asked Questions
The current price of TLIS is 1.90 USD — it has increased by 5.56% in the past 24 hours. Watch TALIS BIOMEDICAL CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange TALIS BIOMEDICAL CORP stocks are traded under the ticker TLIS.
TLIS stock has risen by 17.28% compared to the previous week, the month change is a −53.01% fall, over the last year TALIS BIOMEDICAL CORP has showed a −66.43% decrease.
TLIS reached its all-time high on Feb 12, 2021 with the price of 508.50 USD, and its all-time low was 1.37 USD and was reached on Sep 4, 2024. View more price dynamics on TLIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TLIS stock is 9.55% volatile and has beta coefficient of 3.62. Track TALIS BIOMEDICAL CORP stock price on the chart and check out the list of the most volatile stocks — is TALIS BIOMEDICAL CORP there?
Today TALIS BIOMEDICAL CORP has the market capitalization of 57.04 M, it has increased by 15.38% over the last week.
Yes, you can track TALIS BIOMEDICAL CORP financials in yearly and quarterly reports right on TradingView.
TALIS BIOMEDICAL CORP is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
TLIS net income for the last quarter is −8.85 M USD, while the quarter before that showed −13.04 M USD of net income which accounts for 32.11% change. Track more TALIS BIOMEDICAL CORP financial stats to get the full picture.
No, TLIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 19, 2024, the company has 99.00 employees. See our rating of the largest employees — is TALIS BIOMEDICAL CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TALIS BIOMEDICAL CORP EBITDA is −48.04 M USD, and current EBITDA margin is −15.78 K%. See more stats in TALIS BIOMEDICAL CORP financial statements.
Like other stocks, TLIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TALIS BIOMEDICAL CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TALIS BIOMEDICAL CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TALIS BIOMEDICAL CORP stock shows the sell signal. See more of TALIS BIOMEDICAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.